Globe Newswire (Wed, 11-Feb 4:31 PM ET)
PRNewswire (Wed, 11-Feb 12:15 PM ET)
PRNewswire (Wed, 11-Feb 9:04 AM ET)
POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd.
PRNewswire (Tue, 10-Feb 8:35 PM ET)
Business Wire (Mon, 9-Feb 6:41 PM ET)
Globe Newswire (Mon, 9-Feb 4:06 PM ET)
Globe Newswire (Mon, 9-Feb 12:00 PM ET)
Globe Newswire (Sun, 8-Feb 4:38 PM ET)
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit
PRNewswire (Sat, 7-Feb 8:58 AM ET)
PRNewswire (Sat, 7-Feb 7:34 AM ET)
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
Pomdoctor Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol POM.
As of February 11, 2026, POM stock price climbed to $0.24 with 225,616 million shares trading.
POM has a beta of 7.81, meaning it tends to be more sensitive to market movements. POM has a correlation of 0.03 to the broad based SPY ETF.
POM has a market cap of $28.32 million. This is considered a Sub-Micro Cap stock.
POM support price is $.22 and resistance is $.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that POM shares will trade within this expected range on the day.
